Medicus Pharma (MDCX) CEO Bokhari Raza Receives Awards

What Happened Bokhari Raza, CEO of Medicus Pharma Ltd. (MDCX), reported receiving equity awards on September 4, 2026. The filing shows an acquisition of 2,941,176 shares at $0.17 per share (total reported value $501,471) and a separate derivative award for 500,000 shares listed at $0.00 (reported value $0). These were grants/awards (acquisitions), not open-market purchases or sales.

Key Details

• Transaction date: September 4, 2026; Form 4 filed September 8, 2026 (timely within required reporting window).
• Award 1: 2,941,176 shares acquired at $0.17 each — total reported value $501,471.
• Award 2 (derivative): 500,000 shares listed at $0.00 (derivative/option grant).
• Shares owned after transaction: Not specified in the filing.
• Footnote: The 500,000-share derivative is an option granted Sept 4, 2026 that vests quarterly in four equal installments over one year.
• Filing appears timely (filed two business days after the transaction date, accounting for the Labor Day holiday).

Context These entries reflect equity compensation (a share award and an option grant) rather than stock bought or sold in the open market. The 500,000-share item is a vested-schedule option (derivative) — it does not indicate immediate sale or cashless exercise. Equity awards to executives are common compensation events; they should be interpreted as compensation disclosures rather than direct market-confidence signals.